Central Institute Of Mental Health, Mannheim
Clinical trials sponsored by Central Institute Of Mental Health, Mannheim, explained in plain language.
-
Cannabis compound tested to curb alcohol urges
Disease control Recruiting nowThis study is testing whether adding cannabidiol (CBD), a compound from the cannabis plant, to the standard medication naltrexone can better reduce alcohol cravings in people with alcohol dependence. It will involve 150 adults who are already in a treatment program and report str…
Phase: PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Shock therapy trial offers hope for most resistant schizophrenia
Disease control Recruiting nowThis study is testing whether adding ongoing electroconvulsive therapy (ECT) to standard medication can help prevent relapse in people with severe schizophrenia who haven't responded to other treatments. Researchers will compare patients receiving maintenance ECT plus clozapine a…
Phase: NA • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated Feb 23, 2026 14:56 UTC
-
Brain scans teach patients to cool their emotional storms
Symptom relief Recruiting nowThis study is testing a brain training method to help people with borderline personality disorder manage their intense, unstable emotions. Participants will learn to control activity in a key emotion-processing brain area (the amygdala) using real-time feedback from MRI scans. Th…
Phase: PHASE1, PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Symptom relief
Last updated Mar 16, 2026 15:24 UTC